X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
radiology, nuclear medicine & medical imaging (87) 87
f-18-fet pet (77) 77
positron-emission-tomography (74) 74
humans (65) 65
index medicus (62) 62
glioma (53) 53
brain-tumors (51) 51
brain neoplasms - diagnostic imaging (49) 49
male (42) 42
clinical neurology (41) 41
gliomas (40) 40
oncology (40) 40
o--l-tyrosine pet (37) 37
tyrosine - analogs & derivatives (37) 37
female (36) 36
glioma - diagnostic imaging (36) 36
magnetic resonance imaging (36) 36
pet (36) 36
diagnosis (34) 34
dynamic f-18-fet pet (34) 34
mri (34) 34
middle aged (33) 33
adult (31) 31
cerebral gliomas (31) 31
uptake kinetics (31) 31
tumors (29) 29
glioblastoma (28) 28
positron-emission tomography (28) 28
positron-emission tomography - methods (28) 28
tyrosine (28) 28
fet pet (26) 26
pet imaging (26) 26
low-grade glioma (25) 25
radiopharmaceuticals (25) 25
aged (24) 24
brain tumors (23) 23
high-grade glioma (23) 23
positron emission tomography (23) 23
response assessment (23) 23
fet-pet (22) 22
radiation necrosis (22) 22
brain neoplasms - pathology (21) 21
glioma - pathology (21) 21
tomography (21) 21
brain cancer (20) 20
c-11-methionine pet (20) 20
f-18-fet (20) 20
amino acids (19) 19
brain (19) 19
prognostic value (19) 19
neuroimaging (17) 17
retrospective studies (16) 16
high-grade gliomas (15) 15
malignant glioma (15) 15
medical imaging (15) 15
prognosis (15) 15
surgery (15) 15
tumor (15) 15
positron emission (14) 14
radiotherapy (14) 14
medicine & public health (13) 13
neoplasm grading (13) 13
nuclear magnetic resonance--nmr (13) 13
pets (13) 13
usage (13) 13
brain neoplasms - metabolism (12) 12
care and treatment (12) 12
neurooncology (12) 12
patients (12) 12
amino acid pet (11) 11
differentiation (11) 11
glioma - metabolism (11) 11
phenols (11) 11
pseudoprogression (11) 11
research (11) 11
bevacizumab (10) 10
disease progression (10) 10
f-fet pet (10) 10
fet (10) 10
kinetic analysis (10) 10
recurrent gliomas (10) 10
survival (10) 10
fluorine isotopes (9) 9
glioblastoma-multiforme (9) 9
kinetics (9) 9
neoplasm recurrence, local - diagnostic imaging (9) 9
nuclear medicine (9) 9
performance (9) 9
recurrence (9) 9
tracers (9) 9
tyrosine - metabolism (9) 9
amino-acid (8) 8
central-nervous-system (8) 8
clinical-applications (8) 8
differential uptake (8) 8
f-fet (8) 8
imaging / radiology (8) 8
magnetic resonance imaging - methods (8) 8
magnetic-resonance-spectroscopy (8) 8
o--l-tyrosine (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 2015, Volume 42, Issue 5, pp. 685 - 695
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 03/2019, Volume 46, Issue 3, pp. 540 - 557
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 07/2012, Volume 53, Issue 7, pp. 1048 - 1057
Journal Article
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 06/2011, Volume 52, Issue 6, pp. 856 - 864
The objective of this study was to compare MRI response assessment with metabolic O-(2-F-18-fluoroethyl)-L-tyrosine (F-18-FET) PET response evaluation during... 
F-FET PET response assessment | Recurrent high-grade glioma | MRI response criteria | Antiangiogenic treatment | CRITERIA | BEVACIZUMAB | MRI | antiangiogenic treatment | TUMOR ANGIOGENESIS | F-18-FET PET response assessment | recurrent high-grade glioma | CHEMOTHERAPY | GLIOBLASTOMA | POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY | TREATMENT RESPONSE | IRINOTECAN | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Predictive Value of Tests | Brain Neoplasms - diagnostic imaging | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Male | Positron-Emission Tomography | Tyrosine - analogs & derivatives | Bevacizumab | Antibodies, Monoclonal, Humanized | Astrocytoma - pathology | Treatment Failure | Astrocytoma - drug therapy | Ultrasonography | Angiogenesis Inhibitors - therapeutic use | Adult | Female | Nervous System Diseases - physiopathology | Retrospective Studies | Glioma - surgery | Radiopharmaceuticals | Camptothecin - analogs & derivatives | Postoperative Complications - physiopathology | Camptothecin - therapeutic use | Combined Modality Therapy | Brain Neoplasms - drug therapy | Disease-Free Survival | Magnetic Resonance Imaging | Glioma - diagnostic imaging | Image Processing, Computer-Assisted | Survival Analysis | Nervous System Diseases - etiology | Glioma - drug therapy | Astrocytoma - surgery | Medical imaging | Clinical medicine | Permeability | Vascular endothelial growth factor | Brain cancer | Tumors
Journal Article
JOURNAL OF NUCLEAR MEDICINE, ISSN 0161-5505, 04/2018, Volume 59, Issue 4, pp. 603 - 609
PET imaging of amino acid transport using O-(2-F-18-fluoroethyl)-L-tyrosine (F-18-FET) and proton MR spectroscopy (MRS) imaging of cell turnover measured by... 
MAGNETIC-RESONANCE-SPECTROSCOPY | F-18-FET | glioma | congruency | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PET | CEREBRAL GLIOMAS | MRSI | BRAIN-TUMORS | DIAGNOSTIC PERFORMANCE
Journal Article
Journal Article
JOURNAL OF NUCLEAR MEDICINE, ISSN 0161-5505, 01/2015, Volume 56, Issue 1, pp. 9 - 15
Despite advances in diagnosis and the use of different therapeutic regimens in astrocytic high-grade glioma (HGG), the prognosis for patients remains grim.... 
kinetic analysis | PHASE-III | CEREBRAL GLIOMAS | ADJUVANT TEMOZOLOMIDE | UPTAKE KINETICS | F-18-FET PET | GLIOBLASTOMA | prognostic value | FET PET | high-grade glioma | CONCOMITANT | IMPROVES | ANAPLASTIC GLIOMAS | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Journal Article